2 line items: carbidopa 25MG/levodopa 100MG tab, SA carbidopa 50MG/levodopa 200MG tab, SA awarded for a base year of 5/23/2025 to 5/22/2026 plus 4 on-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0026
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Carbidopa/Levodopa SA Tablet Pre-Solicitation · 36E79725R0008 · Posted Dec 12, 2024
- Last date to order 73% complete
- IDV ceiling
- $10,813,880.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The VA National Acquisition Center awarded an indefinite-delivery contract to Radha Pharmaceuticals Inc. for Carbidopa/Levodopa sustained-action tablets on May 23, 2025, with a ceiling value of $10,813,880.00. This is a single-award contract with no set-aside used. Radha Pharmaceuticals Inc. is a minority-owned manufacturer and distributor of generic pharmaceuticals.
The contract covers two line items: Carbidopa 25MG/Levodopa 100MG tablets and Carbidopa 50MG/Levodopa 200MG tablets, sustained-action formulations. The base period runs from May 23, 2025 to May 22, 2026, with four one-year option periods extending through May 22, 2027. The solicitation (RFP 36E79725R0008) was issued in commercial item format under FAR Part 12 and serves multiple federal agencies including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Products are distributed through VA and DOD Pharmaceutical Prime Vendor Programs. The procurement falls under NAICS code 325412, Pharmaceutical Preparation Manufacturing. Estimated annual requirements include 60,932 bottles of the 25MG/100MG formulation and 58,943 bottles of the 50MG/200MG formulation, each containing 100 tablets. The contract incorporates DEI Clause 52.222-90.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0026?
36E79725D0026 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on May 23, 2025.
How much is contract 36E79725D0026 worth?
36E79725D0026's own ceiling is $10,813,880.
Who can order from contract 36E79725D0026?
36E79725D0026 is a single award indefinite delivery contract.
Was contract 36E79725D0026 competed?
The extent of competition for 36E79725D0026 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV